Offering hope in the fight against one of the world's deadliest cancers, scientists have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body.
"Lung cancer, even when it is discovered early, is often able to metastasise almost immediately and take hold throughout the body," informed Reuben J. Shaw, a professor of molecular and cell biology at Salk Institute for Biological Studies in California.
By identifying the cause of this metastasis, scientists are able to explain why some tumours are more prone to spreading than others.
It is known that about a fifth of lung cancer cases are missing an anti-cancer gene called LKB1. Cancers missing LKB1 are often aggressive, rapidly spreading through the body.
Now, the Salk team has found the connection and a new target for therapy -- a little-known gene called DIXDC1.
The researchers discovered that DIXDC1 receives instructions from LKB1 to go to focal adhesions and change their size and number.
When DIXDC1 is "turned on", half-a-dozen or so focal adhesions grow large and sticky, anchoring cells to their spot.
"The communication between LKB1 and DIXDC1 is responsible for a 'stay-put' signal in cells. DIXDC1 turns out to be inhibited in cancer and metastasis," explained Jonathan Goodwin, study's first author and research student at Salk Institute.
"Patients missing either gene should be sensitive to new therapies targeting focal adhesion enzymes, which are currently being tested in early-stage clinical trials," Shaw added in a paper detailed in the journal Molecular Cell.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
